The Brain Disorders drugs market was valued at USD 79.40 billion in 2021 and is expected to reach USD 125.60 billion by 2029, growing at a CAGR of 5.9% from 2022 to 2029. The prevalence of Brain Disorders is rising globally due to an ageing population and an average lifespan. The need for diagnostic tools has increased recently due to an increase in the prevalence of neurological disorders. Increased awareness, an increase in the prevalence of neurological disorders, and a robust product pipeline for the treatment of Neurorehabilitation are the main drivers of market growth. 533,172 people died from neurological conditions in 2019, of whom 320,043 (60%) were women and 213,129 (40%) were men. The market for Brain Disorders is expected to expand as a result of the burden of neurological disorders, which will increase demand for treatments and efficient treatment options.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
